Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986

I-125 Tumour Localisation Seed — what the literature says.

Four real anchor citations covering Radioactive Seed Localisation (RSL) — the low-dose ¹²⁵I titanium-encapsulated sealed-source technique that displaces the same-morning-of-surgery hookwire for non-palpable breast-conserving surgery. Covers the definitive multicentre RCT (Taylor 2021), the 2024 meta-analysis pooling 19 820 women across 46 studies (Ferreira 2024), the 25 722-seed real-world safety cohort at Memorial Sloan Kettering (Miodownik 2024) and the extension of the technique into non-palpable soft-tissue sarcoma work (Kuo 2016). Every DOI + journal reference verified.

−22 %positive-margin relative reduction vs wire-guided (Ferreira 2024 · 15 610 women)
18 916patients across the 25 722-seed real-world safety cohort (Miodownik 2024)
≤ 5 dayspreop implant window — decouples the seed-implant morning from surgery morning
Product specsGamma-probe family evidence
Filter
Multicentre RCT re-excision + margin — Taylor 2021
13.9 % re-excision · 5.5 % positive margin
I-125 seed (n = 327)
8-centre multicentre trial; specimen weight + volume matched vs hookwire
vs
18.9 % re-excision · 7.8 % positive margin
Hookwire (n = 332)
reoperation reduction 5.0 percentage points favours RSL (P = 0.019)
RCT · RSL vs hookwire2021
13.9 % vs 18.9 %Re-excision rate — RSL vs hookwire — across a multicentre RCT of 659 women / 8 tertiary centres (P = 0.019). Statistically significant reduction in reoperation with I-125 seed localisation. Both radiologists + surgeons rated seed easier to work with (P < 0.001)

Surgical outcomes after radioactive ¹²⁵I seed versus hookwire localization of non-palpable breast cancer — a multicentre randomized clinical trial

BJS (British Journal of Surgery) 108(1):40 – 45 (open access) — Taylor, Bourke, Westcott, Marinovich, Chong, Liang, Hughes, Elder, Saunders

RSL vs wire-guided — pooled effect estimates (Ferreira 2024)
RR 0.78
positive-margin risk ratio (33 studies, 15 610 women)
19 820
women in the RSL vs WGL cohort
46
included studies (10 RCT + 36 observational)
RSL delivers ~ 22 % reduction in positive-surgical-margin rate vs wire-guided localisation across the pooled dataset — statistically significant. Re-excision RR sits at 1.02 (non-inferior). Together this closes the 2000s-era debate on whether RSL was worth adopting for non-palpable breast-conserving surgery.
Meta-analysis · 19 820 women2024
RR 0.78Positive-surgical-margin risk ratio 0.78 (95 % CI 0.70 – 0.87) across 33 studies / 15 610 women — 22 % relative reduction with RSL vs wire-guided localisation. Re-excision risk ratio 1.02 (95 % CI 0.75 – 1.38) — statistically non-inferior. Random-effects model across 46 articles / 10 RCTs / 36 observational studies

Radioactive seed localization for nonpalpable breast lesions — a systematic review and meta-analysis

Diagnostics (Basel) 14(4):441 — Ferreira, de Souza, Pozzo, Ribeiro, Rostelato

RSL safety cohort — Miodownik 2024
25 722
seeds implanted (18 916 patients)
0.027 %
lost-seed incident rate
0
retained-seed events on record
Staff dosimetry discontinued after baseline monitoring showed doses below the 10 mrem annual recording threshold. 99 % of seeds excised within 10 days — the practical window inside which the seed sits in tissue. Establishes RSL as a routine radiation-safety-managed activity, not a specialised programme.
Real-world safety · 25 722 seeds2024
0.027 % lostSeven lost-seed incidents across 25 722 implanted seeds in 18 916 patients over 11 years (Jan 2011 – Dec 2021) — zero retained seeds in the surgical-record archive. Median dose rate at 1 m 0.19 μSv/h; mean breast dose 0.31 cGy (95th %ile 1.00 cGy); 95 % of patients ≤ 1 cGy

Radioactive seed localization is a safe and effective tool for breast cancer surgery — an evaluation of over 25 000 cases

Journal of Radiological Protection 44(1) — Miodownik, Bierman, Thornton, Moo, Feigin, Damato, Le, Williamson, Prasad, Chu, Dauer, Saphier, Zanzonico, Morrow, Bellamy (Memorial Sloan Kettering Cancer Center)

RSL beyond breast — Kuo 2016
US / CT
imaging-guided seed deployment
1 – 4 d
implant-to-surgery scheduling window
Sarcoma
non-palpable soft-tissue extension
Where the surgeon has to locate a non-palpable target in a fibrotic surgical bed — sarcoma re-resection, previously-radiated bed, small retroperitoneal masses — the RSL technique transfers from the breast lumpectomy workflow. The gamma probe pointing at the seed replaces the ultrasound scan on the operating table.
Beyond breast · Soft tissue2016
1 – 4 daysExtension of the established breast RSL technique into non-palpable soft-tissue mass surgery — ultrasound or CT-guided seed deployment; surgery scheduled 1 – 4 days after implant. Applies to sarcoma revision surgery, retroperitoneal masses and any non-palpable target the surgeon has to intra-operatively locate

Preoperative radioactive seed localization of nonpalpable soft-tissue masses — an established localization technique with a new application

Skeletal Radiology 45(11):1553 – 1561 — Kuo, Sabharwal, Wexler, McGill, Weinstein, Ryan

Back to Onco Surgery knowledge hub

White Papers & Background Reading

FILE

AAPM TG-43U1 — Update on the dosimetry parameters for low-energy brachytherapy seeds

AAPM Task Group 43 update — the dosimetry framework governing I-125 (and Pd-103) sealed-source use across brachytherapy and preoperative-localisation applications. Anchor for per-seed activity + dose-rate calculations used in the RSL workflow.

Reference · AAPMDownload
FILE

NCRP Report No. 155 — Management of Radionuclide Therapy Patients

NCRP recommendations covering staff + public radiation-safety management for radionuclide-therapy and preoperative-seed programmes — the framework the RSL programme operates within.

Reference · NCRPDownload
FILE

ACR Practice Parameter for Breast-Conservation Surgery with I-125 Seed Localization

American College of Radiology practice parameter for breast-conservation surgery using I-125 seed preoperative localisation — image-guided implant, gamma-probe intraoperative retrieval, specimen radiography.

Reference · ACRDownload
FILE

AERB — Radioactive Sealed Sources (India) · Type Approval + Consignee Framework

Indian regulatory framework for radioactive sealed-source use including I-125 preoperative-localisation seeds — type approval, transport documentation, seed-tracking + return / disposal chain.

Reference · AERBDownload
FILE

IAEA Safety Standards — Applying Radiation Safety Standards in Nuclear Medicine

IAEA safety framework covering staff + patient + member-of-public radiation-safety obligations in radioguided-surgery programmes including preoperative seed implantation.

Reference · IAEADownload

Literature Radar · auto-updated daily

Latest radioguided-surgery + seed-localisation research

Fresh peer-reviewed papers on I-125 radioactive seed localisation, magnetic-seed + SAVI SCOUT + radar-reflector alternatives, non-palpable breast-conserving surgery outcomes and soft-tissue-sarcoma applications. Auto-updated from Europe PMC.

See all in radar →
Loading recent papers…
Get the weekly digest →